STUDY DESIGN: A retrospective study of a consecutive series of traumatic cervical spine injuries treated with halo vest immobilization (HVI) over an 8-year period at a level 1 trauma center. OBJECTIVE: To assess survivorship, success, and causes of failure of HVI in the management of cervical spine injuries. SUMMARY OF BACKGROUND DATA: The use of HVI has been increasingly questioned as an immobilization technique in cervical trauma due to reports of high complication rates and unacceptable treatment results. It was our hypothesis that selective use of updated HVI could demonstrate higher clinical success rates and lower complication rates compared to several previous landmark studies. METHODS: All patients with traumatic cervical spine injuries treated with HVI between 1998 and 2006 at a single level 1 trauma center were reviewed retrospectively. With Internal Review Board approval, the trauma, spine, and orthotics databases were reviewed for (1) injury type, (2) patient age, (3) complications and comorbidities, (4) survivorship of the device and (5) treatment outcome. RESULTS: Four hundred ninety traumatic cervical spine injuries in 342 patients were treated with HVI. Thirty-one (9%) patients were lost to follow-up. Average age was 41 years (2-94). HVI was used as definitive treatment in 288 (84%) patients and in conjunction with surgical intervention in 54 (16%) patients. One hundred thirteen (35%) complications occurred, the most common of which were pin site infections (39) and instability (38). Two hundred seven (74%) of the 289 halo survivors with appropriate follow-up completed the initially prescribed time period of HVI. Two hundred eight of 247 (85%) halos placed as stand-alone management achieved their intended goal. CONCLUSION: Treatment with HVI was successful in 85% of patients and 74% of survivors completed their intended treatment period. Complications, though common, were mostly not severe. HVI is still a reasonable treatment option in managing cervical spine injuries.
STUDY DESIGN: A retrospective study of a consecutive series of traumatic cervical spine injuries treated with halo vest immobilization (HVI) over an 8-year period at a level 1 trauma center. OBJECTIVE: To assess survivorship, success, and causes of failure of HVI in the management of cervical spine injuries. SUMMARY OF BACKGROUND DATA: The use of HVI has been increasingly questioned as an immobilization technique in cervical trauma due to reports of high complication rates and unacceptable treatment results. It was our hypothesis that selective use of updated HVI could demonstrate higher clinical success rates and lower complication rates compared to several previous landmark studies. METHODS: All patients with traumatic cervical spine injuries treated with HVI between 1998 and 2006 at a single level 1 trauma center were reviewed retrospectively. With Internal Review Board approval, the trauma, spine, and orthotics databases were reviewed for (1) injury type, (2) patient age, (3) complications and comorbidities, (4) survivorship of the device and (5) treatment outcome. RESULTS: Four hundred ninety traumatic cervical spine injuries in 342 patients were treated with HVI. Thirty-one (9%) patients were lost to follow-up. Average age was 41 years (2-94). HVI was used as definitive treatment in 288 (84%) patients and in conjunction with surgical intervention in 54 (16%) patients. One hundred thirteen (35%) complications occurred, the most common of which were pin site infections (39) and instability (38). Two hundred seven (74%) of the 289 halo survivors with appropriate follow-up completed the initially prescribed time period of HVI. Two hundred eight of 247 (85%) halos placed as stand-alone management achieved their intended goal. CONCLUSION: Treatment with HVI was successful in 85% of patients and 74% of survivors completed their intended treatment period. Complications, though common, were mostly not severe. HVI is still a reasonable treatment option in managing cervical spine injuries.
Authors: Younis Kamal; M S Ortho; Hayat Ahmad Khan; Naseemul Gani; Ansar Ul Haq; Snobar Gul; Dara Singh Journal: Int J Health Sci (Qassim) Date: 2014-10
Authors: Jun Jae Shin; Sang Jin Kim; Tae Hong Kim; Hyung Shik Shin; Yong Soon Hwang; Sang Keun Park Journal: Yonsei Med J Date: 2010-09 Impact factor: 2.759